The latest published short-interest report still shows 95,156,102 shares short as of September 15, up 1.84% from the preceding report. The next report is scheduled for October 9. No substantial covering has been confirmed.
Most people who followed $CYDY remember March 30, 2021. The FDA publicly stated that CytoDyn's claims about leronlimab were "misleading and not supported by the data", no benefit was shown in COVID-19 treatment trials. The stock dropped 25%+ that day.
What happened afterward was a class action lawsuit covering investors who held $CYDY between March 27, 2020 and March 30, 2022.
A $500,000 settlement has been reached and terms are now submitted to the court for approval.
Who qualifies?
Anyone who held $CYDY during the class period and suffered losses from the alleged misrepresentations about leronlimab's effectiveness for HIV and COVID-19.
Can I still apply?
Yes, you can submit your application now and it will be processed once claims filing officially opens after court approval.
If you were damaged by this don't forget to check your eligibility. GL!
🚨 $LAKE — THIS ONE IS WORTH WATCHING 🚨
My biggest reason for watching Lakeland Industries ($LAKE) right now:
☣️ PNEUMONIC PLAGUE FEARS + PROTECTIVE EQUIPMENT DEMAND
If concerns around pneumonic plague or other highly contagious respiratory pathogens increase, governments, hospitals, first responders and industrial organizations could increase preparedness spending on protective clothing, respirators and other PPE.
That puts companies like $LAKE in an interesting position.
And this isn't just a speculative "plague stock."
🔥 Fire & Safety is becoming the growth engine
Fire Services grew 49% in FY2026 and now represents roughly half of the company's business.
📈 Revenue is moving in the right direction
FY2026 revenue reached $192.6M, up 15% YoY.
💰 Turnaround potential
Management is targeting high-single-digit revenue growth + positive operating cash flow in FY2027.
🚒 Real-world demand
LAKE makes protective equipment for firefighters, first responders, industrial workers and other high-risk environments.
This isn't some company selling an AI concept — there's an actual product and growing demand behind it.
📉 And here's what gets interesting...
The stock has been beaten down after disappointing earnings, despite meaningful growth in parts of the underlying business.
That's exactly the type of setup I like:
Small market cap + depressed valuation + improving business + potential catalyst = asymmetric upside.
If infectious-disease preparedness becomes a bigger issue, $LAKE could potentially benefit from increased PPE demand at exactly the same time the company is trying to execute its broader turnaround.
I'm NOT saying a pneumonic plague outbreak is coming.
I'm NOT saying $LAKE is guaranteed to explode.
I'm saying the combination of disease-preparedness potential + Fire/Safety growth + a depressed small-cap valuation makes this one worth having on the radar.
👀 $LAKE is officially on my watchlist.
Do your own DD. Small caps can move violently in BOTH directions.
#LAKE #Stocks #SmallCaps #Investing #PPE #FireSafety #Plague #Turnaround